Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Chabner

Showing results (31-40 of 245) with videos related to

Pageof 25
Sort By:
Cancer Treatment Reports|May 1, 1977
Allergic reaction to cyclophosphamide in a mechlorethamine-sensitive patientW E Ross, B A Chabner
Biochimica Et Biophysica Acta|July 13, 1972
Activation and inhibition of carboxypeptidase G 1 by divalent cationsB A Chabner, J R Bertino
Lancet (London, England)|August 31, 1991
Medical oncology in the 1990sB A Chabner, M L Rothenberg
Journal of the National Cancer Institute|May 18, 1988
Meeting highlights: William Guy Forbeck Foundation think tank on "multidrug resistance in cancer chemotherapy"B A Chabner, M M Gottesman
Clinics in Haematology|October 1, 1979
Staging in non-Hodgkin's lymphoma: approach, results and relationship to histopathologyS E Come, B A Chabner
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Multidrug resistanceR L Fine, B A Chabner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Suramin and prostate cancer: where do we go from here?J W Clark, B A Chabner
Transactions & Studies of the College of Physicians of Philadelphia|December 1, 1988
Prospects for the drug treatment of cancerB A Chabner, M J Browne
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Mitotic inhibitorsB A Chabner, E S Chabner
The Journal of Clinical Investigation|August 1, 1973
Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissuesB A Chabner, R C Young
Pageof 25

Showing results (31-40 of 245) with videos related to

Sort By:
Pageof 25
Cancer Treatment Reports|May 1, 1977
Allergic reaction to cyclophosphamide in a mechlorethamine-sensitive patientW E Ross, B A Chabner
Biochimica Et Biophysica Acta|July 13, 1972
Activation and inhibition of carboxypeptidase G 1 by divalent cationsB A Chabner, J R Bertino
Lancet (London, England)|August 31, 1991
Medical oncology in the 1990sB A Chabner, M L Rothenberg
Journal of the National Cancer Institute|May 18, 1988
Meeting highlights: William Guy Forbeck Foundation think tank on "multidrug resistance in cancer chemotherapy"B A Chabner, M M Gottesman
Clinics in Haematology|October 1, 1979
Staging in non-Hodgkin's lymphoma: approach, results and relationship to histopathologyS E Come, B A Chabner
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Multidrug resistanceR L Fine, B A Chabner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Suramin and prostate cancer: where do we go from here?J W Clark, B A Chabner
Transactions & Studies of the College of Physicians of Philadelphia|December 1, 1988
Prospects for the drug treatment of cancerB A Chabner, M J Browne
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Mitotic inhibitorsB A Chabner, E S Chabner
The Journal of Clinical Investigation|August 1, 1973
Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissuesB A Chabner, R C Young
Pageof 25